A comprehensive view of McKesson Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca picks Biologics by McKesson as a specialty pharmacy provider for TRUQAP, an FDA-approved oral treatment for certain types of advanced or metastatic breast cancer

U.S. Patent and Trademark Office Publishes Mckesson Corp's Patent Application for Methods and Systems for Association Rule Mining

Takeda selects Biologics by McKesson as specialty pharmacy provider for FDA-approved oral targeted therapy Fruzaqla for adults with metastatic colorectal cancer; the treatment is the first targeted therapy for the condition in over a decade

McKesson Corporation - Material Agreement - Form 8-K

MCKESSON CORP - (8-K) - Disclosing Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count